Company Toleranzia AB

Equities

TOL

SE0007438577

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm 14:39:42 03/05/2024 BST 5-day change 1st Jan Change
0.56 SEK +3.70% Intraday chart for Toleranzia AB +6.06% +30.84%

Business Summary

Toleranzia AB is a Sweden-based company engaged in the development of a platform technology for treatment of autoimmune diseases. The Company's main project is aimed against an autoimmune nerve-muscle disease and myasthenia gravis. The Company’s platform technology enables the development of therapies targeting the cause of the disease, which in the current situation is the usual treatment.

Number of employees: 12

Managers

Managers TitleAgeSince
Chief Executive Officer 57 -
Director of Finance/CFO 72 29/10/23
Chief Tech/Sci/R&D Officer 65 16/01/18
Corporate Officer/Principal 72 -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 60 31/12/19
Director/Board Member 64 31/12/20
Director/Board Member 63 31/12/17
Director/Board Member 74 31/12/17
Chairman 61 31/12/19
Director/Board Member 63 31/12/16

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 197,070,875 163,552,898 ( 82.99 %) 0 82.99 %

Company contact information

Toleranzia AB

Arvid Wallgrens backe 20 8th Floor

413 46, Gothenburg

+46 7 63 19 98 98

http://www.toleranzia.se
address Toleranzia AB(TOL)
  1. Stock Market
  2. Equities
  3. TOL Stock
  4. Company Toleranzia AB